These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25719949)

  • 1. New drugs 2015, part 1.
    Hussar DA
    Nursing; 2015 Apr; 45(4):40-8; quiz 48-9. PubMed ID: 25719949
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug updates and approvals: 2014 in review.
    Sigler J
    Nurse Pract; 2014 Dec; 39(12):14-23; quiz 23-4. PubMed ID: 25350291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Umeclidinium bromide/vilanterol trifenatate, perampanel, and eslicarbazepine acetate.
    Hussar DA; Dharsi N
    J Am Pharm Assoc (2003); 2014; 54(4):450-2, 454-5. PubMed ID: 25063267
    [No Abstract]   [Full Text] [Related]  

  • 4. Dapagliflozin propanediol, avanafil, and conjugated estrogens/bazedoxifene.
    Hussar DA; Purzycki DJ
    J Am Pharm Assoc (2003); 2014; 54(3):314; 316-8. PubMed ID: 24816359
    [No Abstract]   [Full Text] [Related]  

  • 5. Umeclidinium-vilanterol inhaler approved for COPD.
    Traynor K
    Am J Health Syst Pharm; 2014 Feb; 71(3):174. PubMed ID: 24429003
    [No Abstract]   [Full Text] [Related]  

  • 6. 2015 new drug update.
    Hussar DA
    Consult Pharm; 2015 Apr; 30(4):192-208. PubMed ID: 25893698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fixed combination of long-acting bronchodilators in COPD].
    Steurer J
    Praxis (Bern 1994); 2015 Oct; 104(22):1221. PubMed ID: 26953373
    [No Abstract]   [Full Text] [Related]  

  • 8. [Not Available].
    Steurer J
    Praxis (Bern 1994); 2018 Aug; 107(16):918-919. PubMed ID: 30086696
    [No Abstract]   [Full Text] [Related]  

  • 9. Review: Combination umeclidinium/vilanterol improved health status more than umeclidinium in COPD.
    Stanbrook MB
    Ann Intern Med; 2015 Dec; 163(12):JC10. PubMed ID: 26666800
    [No Abstract]   [Full Text] [Related]  

  • 10. Fluticasone-vilanterol combination approved for COPD.
    Traynor K
    Am J Health Syst Pharm; 2013 Jun; 70(12):1008. PubMed ID: 23719869
    [No Abstract]   [Full Text] [Related]  

  • 11. Umeclidinium/vilanterol fixed-dose combination for COPD.
    Gras J
    Drugs Today (Barc); 2014 Mar; 50(3):231-8. PubMed ID: 24696868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New drugs 2015, part 2.
    Hussar DA
    Nursing; 2015 Jul; 45(7):34-41; quiz 41-2. PubMed ID: 26083291
    [No Abstract]   [Full Text] [Related]  

  • 13. Apremilast, albiglutide, and empagliflozin.
    Hussar DA; Yenner S
    J Am Pharm Assoc (2003); 2014; 54(5):562-6. PubMed ID: 25216888
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug updates and approvals: 2017 in review.
    Mospan G; Mospan C; Vance S; Bradshaw A; Meosky K; Bowles K
    Nurse Pract; 2017 Dec; 42(12):8-16. PubMed ID: 29176433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Umeclidinium bromide and vilanterol in combination for the treatment of chronic obstructive pulmonary disease.
    Kelly E
    Expert Rev Clin Pharmacol; 2014 Jul; 7(4):403-13. PubMed ID: 24909949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Landmark approvals in idiopathic pulmonary fibrosis.
    Ratner M
    Nat Biotechnol; 2014 Nov; 32(11):1069-70. PubMed ID: 25380420
    [No Abstract]   [Full Text] [Related]  

  • 17. New drugs 2014, part 3.
    Hussar DA
    Nursing; 2014 Oct; 44(10):28-34. PubMed ID: 25153167
    [No Abstract]   [Full Text] [Related]  

  • 18. A new conjugated estrogen.
    Med Lett Drugs Ther; 1999 Jul; 41(1058):67-8. PubMed ID: 10445019
    [No Abstract]   [Full Text] [Related]  

  • 19. Dapagliflozin approved for type 2 diabetes.
    Traynor K
    Am J Health Syst Pharm; 2014 Feb; 71(4):263. PubMed ID: 24481146
    [No Abstract]   [Full Text] [Related]  

  • 20. The combination of umeclidinium bromide and vilanterol in the management of chronic obstructive pulmonary disease: current evidence and future prospects.
    Feldman GJ; Edin A
    Ther Adv Respir Dis; 2013 Dec; 7(6):311-9. PubMed ID: 24004659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.